Delivery Order SPE2DB22D3501-SPE2DB25FVP66

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the delivery of 600 mcg/2.4 ml Forteo (teriparatide) pen injections to support military healthcare programs. The delivery order is valued at $3,666.64 and has a firm fixed price. The contract has an ultimate completion date of January 17, 2025....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Forteo 560 mcg/2.24 ml pen injections. The contract has a ceiling value of $12,869.67 and is a firm fixed-price, non-set-aside award with a performance period through May 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the provision of the medication Forteo (teriparatide) 600 mcg/2.4 mL injection pens to the U.S. government. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of up to $999,999,999.00. This single-award IDC serves as the primary vehicle for...
The U.S. government awarded a $3,744.64 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is to provide the pharmaceutical product Forteo 600 MCG/2.4 ML Pen Inj 2.4 ML to the Medical Supply Chain, a component of the Defense Department. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics Agency...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Forteo 600 mcg/2.4 ml pen injections. The contract has a ceiling value of $3,252.95 and a period of performance through November 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Forteo 600 mcg/2.4 ml pen injections. The contract has a firm fixed price of $10,589.55 and a completion date of November 8, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order under contract SPE2DX15D2216 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,342.36 firm fixed-price delivery order is for 600 mcg/2.4 ml Forteo (teriparatide) injection pens, a medication used to treat osteoporosis. The contract has an ultimate completion date of September 25, 2023 and does not utilize a set-aside designation, indicating open...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Forteo 600 mcg/2.4 ml injection pens. The contract has a firm fixed price of $1,772.06 and an ultimate completion date of May 20, 2024. The contract is not set aside and was awarded on a full and open competition basis. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA...
This is a $4,353.34 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,338.79 firm fixed-price delivery order is for the supply of Forteo 600 mcg/2.4 ml pen injections, a specialty medication used in the treatment of osteoporosis. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVP66
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,111.58, is for the delivery of the medication Forteo (teriparatide) 560 mcg/2.24 mL pen injector. The contract does not have a set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order appears to be part of the company's broader support of federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/6/25, 9:52 AM